Page last updated: 2024-08-24

dt 5061 and Anorexia Nervosa

dt 5061 has been researched along with Anorexia Nervosa in 1 studies

*Anorexia Nervosa: An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grieco, KA; Grinspoon, S; Herzog, DB; Klibanski, A; Miller, KK1

Trials

1 trial(s) available for dt 5061 and Anorexia Nervosa

ArticleYear
Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:8

    Topics: Adult; Analysis of Variance; Anorexia Nervosa; Drug Combinations; Ethinyl Estradiol; Female; Ghrelin; Humans; Insulin-Like Growth Factor I; Multivariate Analysis; Norethindrone; Peptide Hormones; Recombinant Proteins

2004